← Patent-cliff monitor Loss of exclusivity January 2043 latest FDA-listed patent expiry
Drug detail Brand name AUVELITY Active ingredient BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE Strength 105MG;30MG Dosage form TABLET, EXTENDED RELEASE Route ORAL Modality Small molecule FDA approval April 2026 Marketing status RX
Listed patents Patent Expires Type 12678506 January 2043 product 12472174 January 2043 use U-4515 12433884 June 2040 use U-4514 12472156 June 2040 use U-4516 12576078 June 2040 use U-4516 11007189 November 2034 use U-4516 9700528 November 2034 use U-4517 11253492 November 2034 use U-4526 9861595 November 2034 use U-4517 9700553 November 2034 use U-4517 9486450 November 2034 use U-4517 9370513 November 2034 use U-4520 9375429 November 2034 use U-4517 9314462 November 2034 use U-4517 9457023 November 2034 use U-4517 11207281 November 2034 use U-4537 10092560 November 2034 use U-4517 10780066 November 2034 use U-4517 9198905 November 2034 use U-4520 9205083 November 2034 use U-4520 9707191 November 2034 use U-4522 10058518 November 2034 use U-4522 11571417 November 2034 use U-4526 10105361 November 2034 use U-4522 10251879 November 2034 use U-4517 11285146 November 2034 use U-4517 11273134 November 2034 use U-4517 11273133 November 2034 use U-4526 11298352 November 2034 use U-4517 11344544 November 2034 use U-4517 11426370 November 2034 use U-4526 11382874 November 2034 use U-4517 11234946 November 2034 use U-4526 9763932 November 2034 use U-4517 11617747 November 2034 use U-4526 11285118 November 2034 use U-4526 11419867 November 2034 use U-4517 11291665 November 2034 use U-4517 9421176 November 2034 use U-4517 9408815 November 2034 use U-4517 9238032 November 2034 use U-4520 9474731 November 2034 use U-4520 9457025 November 2034 use U-4517 9968568 November 2034 use U-4517 10092561 November 2034 use U-4517 9278095 November 2034 use U-4517 10512643 November 2034 use U-4517 10463634 November 2034 use U-4517 10881624 November 2034 use U-4517 10064857 November 2034 use U-4517 9867819 November 2034 use U-4517 9168234 November 2034 use U-4517 10080727 November 2034 use U-4520 11590124 November 2034 use U-4526 11291638 November 2034 use U-4517 8569328 July 2032 product
Regulatory exclusivity Code Expires I-913 April 2029
Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.